MRVIMaravai LifeSciences Holdings, Inc.
$7.47+177% 1Y
$7.47
$2.6952 weeks$8.99
Is the price fair?
What MRVI's price assumes
Maravai LifeSciences Holdings, Inc. did not earn a profit over the last twelve months, so it has no trailing P/E and the price is measured against sales instead: 10.8× revenue.
10.8
Price / sales · no P/E: the last twelve months did not end in a profit
- Price / book
- 11.0
Price / book · today's price, trailing year to Jun 30, 2026
- EV / sales
- 11.2
EV / sales
Details›
- Price / booktoday's price, trailing year to Jun 30, 2026
- 11.0
- EV / EBIToperating margin −56%: the multiple describes the denominator
- not meaningful
- EV / salestoday's price, trailing year to Jun 30, 2026
- 11.2
- Market capitalisation
- $2.26B
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.